ProBio is an outcome-adaptive, multi-arm, open-label, multiple assignment randomized biomarker driven trial in patients with metastatic prostate cancer

ID: 1088057129129385984

linkhttp://probiotrial.org calendar_today23-01-2019 12:53:29